Go Pro
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free CRNC Stock Alerts

Cerence (CRNC) Financials

Cerence logo
$10.31 -0.16 (-1.53%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$10.31 0.00 (0.00%)
As of 08:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Cerence

Annual Income Statements for Cerence

This table shows Cerence's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 5.88 100 -18 46 -311 -56 -588 -19
Consolidated Net Income / (Loss)		 5.88 100 -18 46 -311 -56 -588 -19
Net Income / (Loss) Continuing Operations		 5.88 100 -18 46 -311 -56 -588 -19
Total Pre-Tax Income 		37 11 -23 48 -199 -36 -585 -8.82
Total Operating Income		 37 11 22 61 -184 -27 -580 -2.29
Total Gross Profit		 194 204 223 286 231 199 244 183
Total Revenue		 277 303 331 387 328 294 332 252
Operating Revenue		 277 303 331 387 328 294 332 252
Total Cost of Revenue		 83 99 108 101 97 95 87 69
Operating Cost of Revenue		 83 99 108 101 97 95 87 69
Total Operating Expenses		 157 193 201 226 415 227 824 185
Selling, General & Admin Expense		 20 26 49 57 43 58 52 49
Marketing Expense		 31 36 33 39 31 28 22 22
Research & Development Expense		 81 93 89 112 107 123 122 98
Amortization Expense		 8.84 13 13 13 12 5.85 2.20 1.67
Impairment Charge		 - - 0.00 0.00 214 0.00 609 0.00
Restructuring Charge		 17 25 16 5.09 8.97 12 17 15
Total Other Income / (Expense), net		 -0.05 0.33 -45 -12 -14 -9.19 -4.67 -6.53
Interest Expense		 0.00 0.00 23 14 14 15 13 10
Interest & Investment Income		 0.00 0.00 0.59 0.11 1.01 4.47 5.35 3.85
Other Income / (Expense), net		 -0.05 0.33 -23 1.56 -1.02 1.11 2.53 -0.16
Income Tax Expense		 31 -89 -4.72 2.38 112 20 3.47 9.89
Basic Earnings per Share		 $0.16 $2.76 ($0.50) $1.22 ($7.93) ($1.40) ($14.12) ($0.43)
Weighted Average Basic Shares Outstanding		 36.39M 36.39M 36.43M 37.75M 39.19M 40.22M 41.64M 43.18M
Diluted Earnings per Share		 $0.16 $2.76 ($0.50) $1.17 ($7.93) ($1.40) ($14.12) ($0.43)
Weighted Average Diluted Shares Outstanding		 36.39M 36.39M 36.43M 39.29M 39.19M 40.22M 41.64M 43.18M
Weighted Average Basic & Diluted Shares Outstanding		 - - 37.43M 38.54M 39.94M 41.14M 42.83M 44.94M

Quarterly Income Statements for Cerence

This table shows Cerence's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -12 24 -278 -314 -20 -24 22 -2.72 -13 -5.24 1.67
Consolidated Net Income / (Loss)		 -12 24 -278 -314 -20 -24 22 -2.72 -13 -5.24 1.67
Net Income / (Loss) Continuing Operations		 -12 24 -278 -314 -20 -24 22 -2.72 -13 -5.24 1.67
Total Pre-Tax Income 		0.35 58 -266 -356 -20 -19 16 -0.79 -5.47 30 -2.98
Total Operating Income		 3.90 59 -264 -355 -19 -17 17 -0.95 -1.76 29 -2.44
Total Gross Profit		 58 112 47 50 35 33 60 46 44 99 47
Total Revenue		 81 138 68 71 55 51 78 62 61 115 64
Operating Revenue		 81 138 68 71 55 51 78 62 61 115 64
Total Cost of Revenue		 23 26 21 20 20 18 18 16 17 16 17
Total Operating Expenses		 54 53 311 405 54 50 43 47 46 70 50
Selling, General & Admin Expense		 11 13 17 9.83 13 13 11 12 12 32 13
Marketing Expense		 5.85 6.07 5.62 5.21 4.83 4.77 4.93 5.92 6.20 5.56 6.52
Research & Development Expense		 35 33 32 31 25 21 23 27 26 25 30
Amortization Expense		 0.56 0.55 0.56 0.55 0.55 0.55 0.54 0.58 - 0.00 0.00
Restructuring Charge		 0.84 0.71 4.55 1.49 10 11 2.83 0.85 0.67 7.79 0.13
Total Other Income / (Expense), net		 -3.55 -0.38 -1.95 -1.19 -1.16 -1.68 -1.30 0.16 -3.71 0.75 -0.53
Interest Expense		 3.13 3.24 3.11 3.10 3.10 3.39 2.72 2.41 1.71 1.67 1.48
Interest & Investment Income		 1.23 1.43 1.19 1.29 1.44 1.44 0.92 0.90 0.60 0.87 0.66
Other Income / (Expense), net		 -1.65 1.42 -0.03 0.63 0.50 0.27 0.50 1.67 -2.60 1.55 0.29
Income Tax Expense		 12 34 12 -43 0.03 5.67 -5.60 1.93 7.89 35 -4.65
Basic Earnings per Share		 ($0.29) $0.58 ($6.66) ($7.50) ($0.54) ($0.57) $0.50 ($0.06) ($0.30) ($0.12) $0.04
Weighted Average Basic Shares Outstanding		 40.22M 41.19M 41.72M 41.80M 41.64M 42.90M 43.22M 43.26M 43.18M 44.95M 45.10M
Diluted Earnings per Share		 ($0.29) $0.53 ($6.66) ($7.50) ($0.49) ($0.57) $0.46 ($0.06) ($0.26) ($0.12) $0.04
Weighted Average Diluted Shares Outstanding		 40.22M 49.26M 41.72M 41.80M 41.64M 42.90M 51.53M 43.26M 43.18M 44.95M 46.90M
Weighted Average Basic & Diluted Shares Outstanding		 41.14M 41.67M 41.78M 41.80M 42.83M 43.20M 43.26M 43.32M 44.94M 45.02M 45.19M

Annual Cash Flow Statements for Cerence

This table details how cash moves in and out of Cerence's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Change in Cash & Equivalents		 0.00 0.00 136 -7.64 -34 6.31 20 -37
Net Cash From Operating Activities		 115 88 45 74 -2.14 7.50 17 61
Net Cash From Continuing Operating Activities		 116 88 6.23 74 -2.14 7.50 17 61
Net Income / (Loss) Continuing Operations		 5.88 100 -18 46 -311 -56 -588 -19
Consolidated Net Income / (Loss)		 5.88 100 -18 46 -311 -56 -588 -19
Depreciation Expense		 26 29 30 30 24 16 11 11
Non-Cash Adjustments To Reconcile Net Income		 22 30 34 64 252 45 641 30
Changes in Operating Assets and Liabilities, net		 62 -71 -39 -65 32 2.47 -46 39
Net Cash From Investing Activities		 -86 -4.52 -31 -42 -11 5.82 4.38 -11
Net Cash From Continuing Investing Activities		 -86 -4.52 -31 -42 -11 5.82 4.38 -11
Purchase of Property, Plant & Equipment		 -6.51 -4.52 -19 -12 -17 -5.12 -5.00 -14
Purchase of Investments		 0.00 0.00 -12 -44 -32 -18 0.00 0.00
Sale and/or Maturity of Investments		 - 0.00 0.00 16 37 30 11 5.51
Other Investing Activities, net		 - 0.00 0.00 -1.46 2.02 -1.36 -1.74 -1.71
Net Cash From Financing Activities		 -29 -84 122 -42 -20 -5.33 0.23 -87
Net Cash From Continuing Financing Activities		 -29 -84 122 -42 -20 -5.33 0.23 -87
Repayment of Debt		 0.00 0.00 -278 -6.77 -6.25 -240 -0.42 -87
Repurchase of Common Equity		 0.00 0.00 -9.37 -46 -49 -4.89 -9.87 -2.38
Issuance of Debt		 0.00 0.00 548 0.00 0.00 235 0.00 0.00
Issuance of Common Equity		 0.00 0.00 1.32 12 36 5.63 11 2.88
Other Financing Activities, net		 -29 -84 13 -0.49 -0.42 -0.45 -0.39 -0.41
Effect of Exchange Rate Changes		 0.00 0.00 0.40 1.11 -1.27 -1.68 -1.47 -1.09
Cash Interest Paid		 0.00 0.00 15 9.55 9.09 12 6.03 5.56
Cash Income Taxes Paid		 18 12 2.18 6.18 12 11 10 6.71

Quarterly Cash Flow Statements for Cerence

This table details how cash moves in and out of Cerence's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 15 -2.42 0.44 16 5.96 -17 13 -44 10 8.11 16
Net Cash From Operating Activities		 11 -2.82 1.04 13 6.12 9.25 15 24 13 38 14
Net Cash From Continuing Operating Activities		 11 -2.82 1.04 13 6.12 9.25 15 24 13 38 14
Net Income / (Loss) Continuing Operations		 -12 24 -278 -314 -20 -24 22 -2.72 -13 -5.24 1.67
Consolidated Net Income / (Loss)		 -12 24 -278 -314 -20 -24 22 -2.72 -13 -5.24 1.67
Depreciation Expense		 2.89 2.69 2.70 2.67 2.58 2.45 3.35 2.72 2.04 2.18 2.79
Non-Cash Adjustments To Reconcile Net Income		 12 7.84 266 363 3.92 12 5.77 4.59 8.33 5.30 7.68
Changes in Operating Assets and Liabilities, net		 7.45 -37 10 -39 20 20 -15 19 16 36 1.96
Net Cash From Investing Activities		 8.27 1.19 -0.94 4.08 0.05 0.76 -1.69 -8.08 -1.55 -1.79 1.67
Net Cash From Continuing Investing Activities		 8.27 1.19 -0.94 4.08 0.05 0.76 -1.69 -8.08 -1.55 -1.79 1.67
Purchase of Property, Plant & Equipment		 -1.53 -0.93 -1.85 -0.77 -1.45 -1.36 -2.34 -7.65 -3.00 -2.25 -0.48
Sale and/or Maturity of Investments		 10 2.44 1.47 5.30 1.91 2.49 1.00 - 2.02 0.89 2.54
Other Investing Activities, net		 -0.33 -0.32 -0.57 -0.44 -0.41 -0.37 -0.34 -0.43 -0.57 -0.43 -0.39
Net Cash From Financing Activities		 -4.31 -0.13 0.65 -0.46 0.17 -27 -0.11 -60 0.42 -28 0.55
Net Cash From Continuing Financing Activities		 -4.31 -0.13 0.65 -0.46 0.17 -27 -0.11 -60 0.42 -28 0.55
Repurchase of Common Equity		 -0.06 -6.21 -3.54 -0.11 -0.01 -1.37 -0.80 -0.03 -0.18 -7.54 -0.01
Issuance of Common Equity		 0.94 6.20 4.26 0.18 0.26 1.36 0.81 0.03 0.68 7.50 0.56
Cash Income Taxes Paid		 5.43 3.10 3.15 1.79 2.13 0.01 3.10 1.63 1.97 8.59 0.74

Annual Balance Sheets for Cerence

This table presents Cerence's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Total Assets		 1,484 1,688 1,706 1,318 1,298 702 631
Total Current Assets		 92 250 287 228 226 266 191
Cash & Equivalents		 0.00 136 128 95 101 121 84
Short-Term Investments		 0.00 12 30 20 9.21 5.50 3.43
Accounts Receivable		 66 51 46 45 61 63 59
Prepaid Expenses		 17 44 77 60 47 70 40
Other Current Assets		 9.20 7.26 6.10 7.10 6.94 5.29 4.48
Plant, Property, & Equipment, net		 20 30 32 38 34 30 36
Total Noncurrent Assets		 1,371 1,408 1,387 1,053 1,038 407 404
Goodwill		 1,119 1,128 1,129 891 900 297 299
Noncurrent Deferred & Refundable Income Taxes		 151 161 159 52 47 51 54
Other Noncurrent Operating Assets		 36 73 67 89 76 53 51
Total Liabilities & Shareholders' Equity		 1,484 1,688 1,706 1,318 1,298 702 631
Total Liabilities		 416 728 674 606 603 561 480
Total Current Liabilities		 129 199 165 147 148 217 101
Accounts Payable		 17 8.45 12 10 17 3.96 0.90
Accrued Expenses		 24 66 64 48 49 68 44
Current Deferred Revenue		 88 112 78 73 77 53 52
Other Current Liabilities		 0.00 5.70 4.56 5.07 5.43 4.53 4.34
Total Noncurrent Liabilities		 287 529 508 459 455 344 379
Long-Term Debt		 0.00 267 265 259 276 195 200
Noncurrent Deferred Revenue		 265 213 198 166 146 114 140
Other Noncurrent Operating Liabilities		 22 49 45 33 33 35 39
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,068 960 1,032 713 695 141 151
Total Preferred & Common Equity		 1,068 960 1,032 713 695 141 151
Total Common Equity		 1,068 960 1,032 713 695 141 151
Common Stock		 0.00 975 1,003 1,030 1,057 1,089 1,117
Retained Earnings		 0.00 -18 28 -283 -334 -922 -940
Accumulated Other Comprehensive Income / (Loss)		 -29 3.71 1.63 -34 -28 -26 -25

Quarterly Balance Sheets for Cerence

This table presents Cerence's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 12/31/2022 3/31/2023 6/30/2023 12/31/2023 3/31/2024 6/30/2024 12/31/2024 3/31/2025 6/30/2025 12/31/2025 3/31/2026
Total Assets		 1,348 1,335 1,312 1,265 987 674 618 666 637 602 617
Total Current Assets		 242 232 219 228 233 240 200 232 190 186 204
Cash & Equivalents		 91 95 86 99 99 116 104 117 74 92 108
Short-Term Investments		 17 12 17 9.78 9.36 5.44 3.89 5.41 5.45 2.54 0.00
Accounts Receivable		 66 61 57 59 67 73 48 65 62 51 64
Prepaid Expenses		 61 56 52 56 52 40 40 40 44 36 28
Other Current Assets		 7.78 7.71 7.59 5.57 5.30 5.56 4.74 4.74 4.70 4.35 4.48
Plant, Property, & Equipment, net		 37 36 35 33 32 31 29 29 35 36 34
Total Noncurrent Assets		 1,069 1,068 1,058 1,004 722 404 388 404 412 379 379
Goodwill		 902 904 905 906 651 292 289 293 299 299 297
Noncurrent Deferred & Refundable Income Taxes		 54 54 52 17 7.06 50 46 55 59 33 37
Other Noncurrent Operating Assets		 92 89 83 70 55 54 50 55 54 48 45
Total Liabilities & Shareholders' Equity		 1,348 1,335 1,312 1,265 987 674 618 666 637 602 617
Total Liabilities		 628 626 609 534 524 520 497 516 481 452 458
Total Current Liabilities		 165 166 168 120 107 183 152 158 108 99 107
Accounts Payable		 19 19 16 19 16 10 7.61 6.63 5.54 4.86 7.52
Accrued Expenses		 52 53 47 52 40 38 33 38 45 37 38
Current Deferred Revenue		 76 76 75 43 45 44 48 50 53 52 57
Other Current Liabilities		 5.76 6.00 5.51 5.68 5.19 4.65 3.83 3.96 4.16 4.47 4.10
Total Noncurrent Liabilities		 463 460 441 414 417 337 345 358 374 352 351
Long-Term Debt		 267 265 255 277 279 193 196 198 199 172 173
Noncurrent Deferred Revenue		 162 160 153 101 103 109 113 120 133 142 141
Other Noncurrent Operating Liabilities		 33 35 33 35 35 34 35 41 42 39 37
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 720 709 703 731 463 154 121 149 156 150 159
Total Preferred & Common Equity		 720 709 703 731 463 154 121 149 156 150 159
Total Common Equity		 720 709 703 731 463 154 121 149 156 150 159
Common Stock		 1,024 1,038 1,050 1,064 1,078 1,084 1,097 1,102 1,109 1,122 1,129
Retained Earnings		 -280 -306 -322 -310 -588 -901 -946 -924 -927 -946 -944
Accumulated Other Comprehensive Income / (Loss)		 -24 -23 -25 -23 -27 -29 -30 -29 -26 -26 -27

Annual Metrics And Ratios for Cerence

This table displays calculated financial ratios and metrics derived from Cerence's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
DEI Shares Outstanding		 0.00 0.00 36,722,585.00 38,006,493.00 - - - 43,319,651.00
DEI Adjusted Shares Outstanding		 0.00 0.00 36,722,585.00 38,006,493.00 - - - 43,319,651.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -0.50 1.21 - - - -0.43
Growth Metrics		 - - - - - - - -
Revenue Growth		 0.00% 9.51% 9.12% 16.99% -15.31% -10.19% 12.57% -24.05%
EBITDA Growth		 0.00% -36.02% -27.17% 214.95% -275.81% 93.77% -5,537.92% 101.43%
EBIT Growth		 0.00% -69.61% -107.94% 7,099.66% -398.22% 85.92% -2,113.06% 99.58%
NOPAT Growth		 0.00% 1,551.91% -83.86% 266.91% -323.99% 85.25% -2,032.20% 99.61%
Net Income Growth		 0.00% 1,604.95% -118.27% 350.56% -777.28% 81.90% -945.40% 96.82%
EPS Growth		 0.00% 1,625.00% -118.12% 334.00% -777.78% 82.35% -908.57% 96.95%
Operating Cash Flow Growth		 0.00% -23.59% -49.14% 66.09% -102.87% 450.70% 129.34% 255.74%
Free Cash Flow Firm Growth		 0.00% 0.00% 99.83% 466.48% 2,428.98% -108.13% 1,328.64% -81.47%
Invested Capital Growth		 0.00% 0.00% 1.62% 4.76% -24.67% -0.78% -65.57% -10.13%
Revenue Q/Q Growth		 0.00% 0.00% 2.65% 1.73% -10.86% 8.32% -7.26% 2.37%
EBITDA Q/Q Growth		 0.00% 0.00% 42.67% -2.77% -298.43% 95.81% -3.90% 241.65%
EBIT Q/Q Growth		 0.00% 0.00% 90.74% -4.11% -436.33% 89.88% -3.77% 85.42%
NOPAT Q/Q Growth		 0.00% 0.00% 112.78% -5.59% -32.25% 89.56% -4.15% 88.40%
Net Income Q/Q Growth		 0.00% 0.00% -126.63% -1.49% -327.50% 79.53% -1.53% 27.38%
EPS Q/Q Growth		 0.00% 0.00% -126.60% -4.10% -326.34% 79.91% -1.44% 34.85%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 17.90% -3.74% -108.18% 186.06% -23.02% 12.17%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 45.63% 429.64% -134.16% -10.01% 47.01%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.57% 0.08% -21.02% -1.89% -5.10% -4.52%
Profitability Metrics		 - - - - - - - -
Gross Margin		 70.05% 67.25% 67.41% 73.90% 70.37% 67.68% 73.69% 72.74%
EBITDA Margin		 22.59% 13.20% 8.81% 23.71% -49.23% -3.41% -170.97% 3.22%
Operating Margin		 13.30% 3.58% 6.78% 15.65% -56.22% -9.24% -174.94% -0.91%
EBIT Margin		 13.29% 3.69% -0.27% 16.05% -56.53% -8.86% -174.18% -0.97%
Profit (Net Income) Margin		 2.12% 33.06% -5.53% 11.85% -94.80% -19.10% -177.40% -7.43%
Tax Burden Percent		 15.98% 896.53% 79.50% 95.08% 156.39% 154.59% 100.59% 212.15%
Interest Burden Percent		 100.00% 100.00% 2,594.59% 77.66% 107.22% 139.47% 101.25% 359.89%
Effective Tax Rate		 84.02% -796.53% 0.00% 4.92% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 18.22% 1.46% 5.18% -12.95% -2.23% -71.07% -0.58%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% -52.80% -4.98% -159.09% -27.16% -189.93% -13.55%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% -3.26% -0.58% -22.68% -5.76% -69.62% -12.25%
Return on Equity (ROE)		 0.00% 0.00% -1.81% 4.61% -35.63% -7.99% -140.69% -12.83%
Cash Return on Invested Capital (CROIC)		 0.00% -181.78% -0.15% 0.54% 15.20% -1.44% 26.49% 10.10%
Operating Return on Assets (OROA)		 0.00% 0.75% -0.06% 3.66% -12.26% -1.99% -57.74% -0.37%
Return on Assets (ROA)		 0.00% 6.76% -1.16% 2.70% -20.56% -4.30% -58.81% -2.81%
Return on Common Equity (ROCE)		 0.00% 0.00% -1.81% 4.61% -35.63% -7.99% -140.69% -12.83%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 9.39% -1.91% 4.45% -43.60% -8.10% -416.79% 0.00%
Net Operating Profit after Tax (NOPAT)		 5.89 97 16 58 -129 -19 -406 -1.60
NOPAT Margin		 2.13% 32.08% 4.74% 14.88% -39.36% -6.47% -122.46% -0.64%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 54.26% 10.17% 146.15% 24.93% 118.86% 12.98%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -0.46%
Cost of Revenue to Revenue		 29.95% 32.75% 32.59% 26.11% 29.63% 32.32% 26.31% 27.26%
SG&A Expenses to Revenue		 7.17% 8.55% 14.92% 14.72% 13.01% 19.66% 15.83% 19.37%
R&D to Revenue		 29.23% 30.68% 26.86% 28.95% 32.67% 41.88% 36.67% 38.83%
Operating Expenses to Revenue		 56.74% 63.67% 60.64% 58.25% 126.59% 76.92% 248.63% 73.65%
Earnings before Interest and Taxes (EBIT)		 37 11 -0.89 62 -185 -26 -577 -2.45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 63 40 29 92 -161 -10 -567 8.10
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 1.87 3.54 0.87 1.18 0.93 3.58
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 5.42 9.43 1.89 2.79 0.40 2.14
Price to Earnings (P/E)		 0.00 0.00 0.00 79.59 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 1.26% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 1.77 3.30 0.89 1.15 0.97 2.48
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 5.80 9.71 2.33 3.32 0.85 2.59
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 65.86 40.93 0.00 0.00 0.00 80.51
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 60.46 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 122.28 65.23 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 42.87 50.52 0.00 130.24 16.47 10.66
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 627.44 5.04 0.00 1.87 23.25
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.00 0.00 0.28 0.26 0.38 0.40 2.00 1.33
Long-Term Debt to Equity		 0.00 0.00 0.28 0.26 0.36 0.40 1.38 1.33
Financial Leverage		 0.00 0.00 0.06 0.12 0.14 0.21 0.37 0.90
Leverage Ratio		 0.00 1.39 1.56 1.70 1.73 1.86 2.39 4.57
Compound Leverage Factor		 0.00 1.39 40.57 1.32 1.86 2.59 2.42 16.44
Debt to Total Capital		 0.00% 0.00% 22.15% 20.82% 27.50% 28.42% 66.64% 57.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.51% 0.48% 1.11% 0.00% 20.59% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 21.64% 20.34% 26.38% 28.42% 46.05% 57.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 100.00% 77.85% 79.18% 72.50% 71.58% 33.36% 43.00%
Debt to EBITDA		 0.00 0.00 9.37 2.96 -1.67 -27.45 -0.50 24.66
Net Debt to EBITDA		 0.00 0.00 4.30 1.15 -0.89 -15.42 -0.27 13.86
Long-Term Debt to EBITDA		 0.00 0.00 9.15 2.89 -1.61 -27.45 -0.34 24.66
Debt to NOPAT		 0.00 0.00 17.39 4.71 -2.10 -14.49 -0.69 -124.52
Net Debt to NOPAT		 0.00 0.00 7.99 1.83 -1.11 -8.14 -0.37 -69.99
Long-Term Debt to NOPAT		 0.00 0.00 17.00 4.60 -2.01 -14.49 -0.48 -124.52
Altman Z-Score		 0.00 0.00 1.70 3.71 0.17 0.69 -3.85 -0.86
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 0.00 0.72 1.26 1.74 1.55 1.52 1.22 1.89
Quick Ratio		 0.00 0.51 1.00 1.24 1.09 1.16 0.88 1.45
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -971 -1.63 5.99 151 -12 151 28
Operating Cash Flow to CapEx		 1,770.49% 1,949.77% 235.58% 617.49% -12.26% 146.33% 344.20% 426.11%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -0.07 0.43 10.52 -0.83 12.06 2.74
Operating Cash Flow to Interest Expense		 0.00 0.00 1.97 5.31 -0.15 0.51 1.37 5.98
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 1.13 4.45 -1.36 0.16 0.97 4.58
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.00 0.20 0.21 0.23 0.22 0.23 0.33 0.38
Accounts Receivable Turnover		 0.00 4.61 5.67 8.03 7.24 5.54 5.35 4.14
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 15.08 13.33 12.69 9.48 8.21 10.34 7.64
Accounts Payable Turnover		 0.00 5.95 8.58 10.07 8.83 6.99 8.37 28.25
Days Sales Outstanding (DSO)		 0.00 79.17 64.34 45.47 50.45 65.91 68.28 88.21
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 61.31 42.53 36.26 41.34 52.25 43.58 12.92
Cash Conversion Cycle (CCC)		 0.00 17.86 21.81 9.20 9.11 13.66 24.70 75.29
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 0.00 1,068 1,085 1,137 857 850 293 263
Invested Capital Turnover		 0.00 0.57 0.31 0.35 0.33 0.35 0.58 0.91
Increase / (Decrease) in Invested Capital		 0.00 1,068 17 52 -281 -6.72 -557 -30
Enterprise Value (EV)		 0.00 0.00 1,920 3,758 764 977 283 652
Market Capitalization		 0.00 0.00 1,795 3,653 620 822 132 540
Book Value per Share		 $0.00 $29.35 $26.14 $27.15 $18.10 $17.23 $3.38 $3.48
Tangible Book Value per Share		 $0.00 ($3.21) ($5.82) ($3.21) ($4.76) ($5.19) ($3.77) ($3.42)
Total Capital		 0.00 1,068 1,233 1,303 983 971 423 350
Total Debt		 0.00 0.00 273 271 270 276 282 200
Total Long-Term Debt		 0.00 0.00 267 265 259 276 195 200
Net Debt		 0.00 0.00 125 105 144 155 151 112
Capital Expenditures (CapEx)		 6.51 4.52 19 12 17 5.12 5.00 14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -37 -90 -31 -24 -33 8.81 2.12
Debt-free Net Working Capital (DFNWC)		 0.00 -37 58 128 91 78 136 90
Net Working Capital (NWC)		 0.00 -37 51 122 80 78 49 90
Net Nonoperating Expense (NNE)		 0.01 -2.98 34 12 182 37 182 17
Net Nonoperating Obligations (NNO)		 0.00 0.00 125 105 144 155 151 112
Total Depreciation and Amortization (D&A)		 26 29 30 30 24 16 11 11
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -12.13% -27.19% -7.97% -7.24% -11.12% 2.66% 0.84%
Debt-free Net Working Capital to Revenue		 0.00% -12.13% 17.44% 33.06% 27.88% 26.36% 40.96% 35.57%
Net Working Capital to Revenue		 0.00% -12.13% 15.55% 31.44% 24.55% 26.36% 14.69% 35.57%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.57) $1.22 ($7.93) ($1.40) ($14.12) ($0.43)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 36.43M 37.75M 39.19M 40.22M 41.64M 43.18M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.57) $1.17 ($7.93) ($1.40) ($14.12) ($0.43)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 36.43M 39.29M 39.19M 40.22M 41.64M 43.18M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 37.43M 38.54M 39.94M 41.14M 42.83M 44.94M
Normalized Net Operating Profit after Tax (NOPAT)		 38 25 27 62 27 -11 32 9.19
Normalized NOPAT Margin		 13.60% 8.35% 8.23% 16.13% 8.19% -3.63% 9.78% 3.65%
Pre Tax Income Margin		 13.29% 3.69% -6.96% 12.47% -60.62% -12.36% -176.35% -3.50%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 -0.04 4.44 -12.88 -1.77 -46.00 -0.24
NOPAT to Interest Expense		 0.00 0.00 0.69 4.12 -8.97 -1.29 -32.34 -0.16
EBIT Less CapEx to Interest Expense		 0.00 0.00 -0.88 3.58 -14.09 -2.11 -46.40 -1.64
NOPAT Less CapEx to Interest Expense		 0.00 0.00 -0.15 3.26 -10.18 -1.64 -32.74 -1.56
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% -835.22% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% -886.37% 99.73% -15.77% -8.70% -1.68% -12.72%

Quarterly Metrics And Ratios for Cerence

This table displays calculated financial ratios and metrics derived from Cerence's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - 43,198,993.00 43,258,066.00 43,319,651.00 - 45,018,082.00
DEI Adjusted Shares Outstanding		 - - - - - - 43,198,993.00 43,258,066.00 43,319,651.00 - 45,018,082.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - 0.50 -0.06 -0.31 - 0.04
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 38.90% 65.36% -0.83% 14.40% -32.14% -63.21% 15.02% -11.77% 10.65% 126.10% -17.71%
EBITDA Growth		 102.29% 829.54% -1,702.66% -4,643.21% -414.45% -122.68% 108.10% 100.98% 85.57% 332.45% -97.00%
EBIT Growth		 100.98% 3,356.34% -1,252.96% -3,264.15% -933.33% -127.77% 106.75% 100.20% 76.68% 285.23% -112.08%
NOPAT Growth		 18.97% 1,835.21% -1,182.35% -4,074.86% 89.65% -149.36% 112.65% 99.73% 90.84% 56.90% -107.31%
Net Income Growth		 94.98% 1,205.51% -965.49% -1,805.46% -76.73% -201.81% 107.79% 99.13% 34.56% 78.43% -92.27%
EPS Growth		 95.05% 1,160.00% -924.62% -1,729.27% -68.97% -207.55% 106.91% 99.20% 46.94% 78.95% -91.30%
Operating Cash Flow Growth		 327.30% -32.91% -84.07% 256.79% -45.68% 428.74% 1,381.42% 84.41% 108.54% 309.49% -8.79%
Free Cash Flow Firm Growth		 -202.82% -96.10% -82.89% 45.71% 540.87% 5,385.23% 607.44% -89.58% -94.78% -94.54% -83.77%
Invested Capital Growth		 -0.78% 1.46% -27.42% -64.41% -65.57% -70.15% -54.69% -10.67% -10.13% -14.50% -21.53%
Revenue Q/Q Growth		 30.98% 71.28% -50.97% 4.00% -22.31% -7.13% 53.27% -20.22% -2.57% 89.77% -44.22%
EBITDA Q/Q Growth		 169.26% 1,121.04% -517.48% -34.35% 95.41% 11.94% 249.12% -83.75% -167.62% 1,518.85% -98.08%
EBIT Q/Q Growth		 121.34% 2,570.32% -540.67% -33.99% 94.71% 11.02% 207.14% -95.94% -702.21% 806.85% -106.99%
NOPAT Q/Q Growth		 -2,085.91% 118.46% -870.68% -34.24% 94.58% 11.94% 297.49% -102.83% -85.87% -314.16% 66.51%
Net Income Q/Q Growth		 29.80% 306.52% -1,265.18% -12.80% 93.49% -18.97% 189.16% -112.56% -391.03% 60.79% 131.93%
EPS Q/Q Growth		 29.27% 282.76% -1,356.60% -12.61% 93.47% -16.33% 180.70% -113.04% -333.33% 53.85% 133.33%
Operating Cash Flow Q/Q Growth		 237.34% -125.00% 137.09% 1,131.03% -52.42% 51.33% 67.13% 53.25% -46.20% 197.16% -62.77%
Free Cash Flow Firm Q/Q Growth		 -158.08% 109.08% 362.51% 497.71% 75.71% 12.92% -40.35% -91.20% -11.88% 17.99% 77.37%
Invested Capital Q/Q Growth		 -1.89% 4.99% -29.73% -50.84% -5.10% -8.97% 6.69% -3.09% -4.52% -13.40% -2.07%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 71.49% 80.96% 69.21% 71.50% 63.67% 64.98% 77.15% 73.73% 72.55% 86.33% 73.68%
EBITDA Margin		 6.36% 45.32% -385.86% -498.47% -29.46% -27.93% 27.17% 5.53% -3.84% 28.72% 0.99%
Operating Margin		 4.82% 42.35% -389.80% -503.13% -35.08% -33.27% 22.24% -1.52% -2.91% 25.47% -3.81%
EBIT Margin		 2.78% 43.37% -389.84% -502.25% -34.17% -32.74% 22.88% 1.16% -7.20% 26.82% -3.36%
Profit (Net Income) Margin		 -14.30% 17.25% -409.84% -444.50% -37.25% -47.72% 27.76% -4.37% -22.03% -4.55% 2.61%
Tax Burden Percent		 -3,338.73% 40.99% 104.37% 88.05% 100.16% 130.46% 134.90% 344.87% 244.35% -17.43% -56.18%
Interest Burden Percent		 15.40% 96.99% 100.73% 100.51% 108.85% 111.74% 89.93% -108.83% 125.24% 97.41% 138.13%
Effective Tax Rate		 3,438.73% 59.01% 0.00% 0.00% 0.00% 0.00% -34.90% 0.00% 0.00% 117.43% 0.00%
Return on Invested Capital (ROIC)		 -55.59% 6.84% -127.59% -214.39% -14.25% -9.81% 16.75% -0.90% -1.84% -5.68% -3.18%
ROIC Less NNEP Spread (ROIC-NNEP)		 23.80% 6.74% -186.00% -255.40% -18.79% -17.92% 15.57% -2.40% -11.04% -5.80% 0.22%
Return on Net Nonoperating Assets (RNNOA)		 5.05% 1.49% -50.45% -94.61% -6.89% -6.45% 7.59% -2.12% -9.98% -4.76% 0.14%
Return on Equity (ROE)		 -50.54% 8.33% -178.04% -309.00% -21.14% -16.26% 24.33% -3.02% -11.82% -10.44% -3.03%
Cash Return on Invested Capital (CROIC)		 -1.44% -6.46% 12.01% 28.64% 26.49% 28.85% 17.85% 6.54% 10.10% 15.79% 15.14%
Operating Return on Assets (OROA)		 0.63% 11.59% -117.02% -180.79% -11.33% -8.49% 7.04% 0.44% -2.72% 13.90% -1.58%
Return on Assets (ROA)		 -3.22% 4.61% -123.02% -160.00% -12.35% -12.37% 8.54% -1.64% -8.32% -2.36% 1.23%
Return on Common Equity (ROCE)		 -50.54% 8.33% -178.04% -309.00% -21.14% -16.26% 24.33% -3.02% -11.82% -10.44% -3.03%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -4.14% -60.88% -375.63% 0.00% -527.10% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -130 24 -185 -248 -13 -12 23 -0.66 -1.23 -5.11 -1.71
NOPAT Margin		 -161.06% 17.36% -272.86% -352.19% -24.56% -23.29% 30.01% -1.07% -2.03% -4.44% -2.67%
Net Nonoperating Expense Percent (NNEP)		 -79.39% 0.10% 58.41% 41.02% 4.54% 8.11% 1.17% 1.50% 9.20% 0.12% -3.40%
Return On Investment Capital (ROIC_SIMPLE)		 - 2.38% - - - -3.15% 5.75% -0.19% -0.35% -1.58% -0.52%
Cost of Revenue to Revenue		 28.51% 19.04% 30.79% 28.50% 36.33% 35.02% 22.85% 26.27% 27.45% 13.67% 26.32%
SG&A Expenses to Revenue		 14.18% 9.25% 24.56% 13.94% 24.06% 25.06% 14.36% 19.83% 20.58% 27.80% 19.93%
R&D to Revenue		 43.51% 24.08% 46.95% 44.21% 46.03% 41.00% 29.91% 43.63% 43.54% 21.46% 47.20%
Operating Expenses to Revenue		 66.66% 38.62% 459.01% 574.63% 98.76% 98.25% 54.90% 75.26% 75.46% 60.86% 77.49%
Earnings before Interest and Taxes (EBIT)		 2.25 60 -264 -354 -19 -17 18 0.73 -4.37 31 -2.16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 5.13 63 -262 -352 -16 -14 21 3.44 -2.33 33 0.64
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.18 1.08 1.42 0.77 0.93 2.79 2.29 2.84 3.58 3.19 1.79
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.79 2.27 1.88 0.33 0.40 1.38 1.34 1.80 2.14 1.52 0.94
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,434.02 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.07% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.15 1.07 1.31 0.88 0.97 1.81 1.68 2.04 2.48 2.45 1.56
Enterprise Value to Revenue (EV/Rev)		 3.32 2.73 2.35 0.76 0.85 1.97 1.87 2.28 2.59 1.76 1.15
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 20.79 0.00 0.00 0.00 0.00 0.00 0.00 80.51 10.07 10.02
Enterprise Value to EBIT (EV/EBIT)		 0.00 29.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.37 13.90
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,509.49 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 130.24 140.29 635.68 12.19 16.47 16.46 10.90 10.29 10.66 6.21 3.94
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 9.16 1.62 1.87 2.88 5.86 29.43 23.25 14.30 9.08
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.40 0.38 0.60 1.82 2.00 2.12 1.73 1.28 1.33 1.14 1.09
Long-Term Debt to Equity		 0.40 0.38 0.60 1.25 1.38 1.63 1.32 1.28 1.33 1.14 1.09
Financial Leverage		 0.21 0.22 0.27 0.37 0.37 0.36 0.49 0.88 0.90 0.82 0.65
Leverage Ratio		 1.86 1.80 1.98 2.32 2.39 2.21 2.70 4.23 4.57 4.50 4.17
Compound Leverage Factor		 0.29 1.75 1.99 2.33 2.60 2.47 2.43 -4.60 5.72 4.38 5.76
Debt to Total Capital		 28.42% 27.51% 37.57% 64.52% 66.64% 67.97% 63.32% 56.09% 57.00% 53.33% 52.13%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 20.01% 20.59% 15.91% 14.76% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 28.42% 27.51% 37.57% 44.51% 46.05% 52.06% 48.56% 56.09% 57.00% 53.33% 52.13%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 71.58% 72.49% 62.43% 35.48% 33.36% 32.03% 36.68% 43.91% 43.00% 46.67% 47.87%
Debt to EBITDA		 -27.45 6.05 -1.39 -0.51 -0.50 -0.40 -0.71 -34.78 24.66 3.11 4.96
Net Debt to EBITDA		 -15.42 3.51 -0.81 -0.28 -0.27 -0.23 -0.37 -20.94 13.86 1.40 1.85
Long-Term Debt to EBITDA		 -27.45 6.05 -1.39 -0.35 -0.34 -0.30 -0.55 -34.78 24.66 3.11 4.96
Debt to NOPAT		 -14.49 -6.25 -1.89 -0.72 -0.69 -0.56 -0.98 -14.38 -124.52 465.38 -7.58
Net Debt to NOPAT		 -8.14 -3.63 -1.11 -0.40 -0.37 -0.32 -0.52 -8.65 -69.99 209.11 -2.83
Long-Term Debt to NOPAT		 -14.49 -6.25 -1.89 -0.50 -0.48 -0.43 -0.76 -14.38 -124.52 465.38 -7.58
Altman Z-Score		 0.76 1.08 -0.46 -2.84 -1.23 -1.34 -0.94 -0.94 -0.87 -0.69 -1.10
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.52 1.90 2.18 1.31 1.22 1.32 1.47 1.77 1.89 1.88 1.90
Quick Ratio		 1.16 1.39 1.64 1.06 0.88 1.02 1.19 1.31 1.45 1.47 1.60
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -123 11 52 309 544 614 366 32 28 34 59
Operating Cash Flow to CapEx		 737.26% -302.36% 56.59% 1,660.47% 422.89% 680.44% 660.09% 309.82% 424.64% 1,684.93% 2,926.76%
Free Cash Flow to Firm to Interest Expense		 -39.39 3.46 16.64 99.71 175.32 180.99 134.87 13.38 16.66 20.13 40.25
Operating Cash Flow to Interest Expense		 3.59 -0.87 0.34 4.14 1.97 2.73 5.69 9.84 7.48 22.76 9.55
Operating Cash Flow Less CapEx to Interest Expense		 3.11 -1.16 -0.26 3.89 1.51 2.33 4.83 6.66 5.72 21.41 9.22
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.23 0.27 0.30 0.36 0.33 0.26 0.31 0.38 0.38 0.52 0.47
Accounts Receivable Turnover		 5.54 5.58 5.44 5.51 5.35 4.59 3.86 3.64 4.14 6.39 4.70
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 8.21 10.04 10.27 10.89 10.34 7.87 8.25 7.50 7.64 9.61 9.53
Accounts Payable Turnover		 6.99 4.98 5.15 6.84 8.37 5.88 6.56 9.08 28.25 10.67 9.27
Days Sales Outstanding (DSO)		 65.91 65.41 67.14 66.26 68.28 79.53 94.61 100.19 88.21 57.12 77.69
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 52.25 73.30 70.89 53.37 43.58 62.10 55.62 40.22 12.92 34.19 39.37
Cash Conversion Cycle (CCC)		 13.66 -7.89 -3.76 12.89 24.70 17.43 38.98 59.97 75.29 22.93 38.33
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 850 892 627 308 293 266 284 275 263 228 223
Invested Capital Turnover		 0.35 0.39 0.47 0.61 0.58 0.42 0.56 0.84 0.91 1.28 1.19
Increase / (Decrease) in Invested Capital		 -6.72 13 -237 -558 -557 -626 -343 -33 -30 -39 -61
Enterprise Value (EV)		 977 954 820 272 283 482 476 561 652 558 348
Market Capitalization		 822 793 656 118 132 336 341 442 540 480 284
Book Value per Share		 $17.23 $17.75 $11.12 $3.69 $3.38 $2.82 $3.46 $3.60 $3.48 $3.35 $3.52
Tangible Book Value per Share		 ($5.19) ($4.34) ($4.56) ($3.36) ($3.77) ($3.95) ($3.35) ($3.31) ($3.42) ($3.31) ($3.07)
Total Capital		 971 1,009 742 435 423 377 407 354 350 322 331
Total Debt		 276 277 279 280 282 256 258 199 200 172 173
Total Long-Term Debt		 276 277 279 193 195 196 198 199 200 172 173
Net Debt		 155 161 164 154 151 146 135 120 112 77 64
Capital Expenditures (CapEx)		 1.53 0.93 1.85 0.77 1.45 1.36 2.34 7.65 3.00 2.25 0.48
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -33 -0.14 18 22 8.81 0.05 12 3.41 2.12 -7.77 -11
Debt-free Net Working Capital (DFNWC)		 78 108 126 143 136 108 134 83 90 87 97
Net Working Capital (NWC)		 78 108 126 56 49 48 74 83 90 87 97
Net Nonoperating Expense (NNE)		 -119 0.16 93 65 6.96 12 1.75 2.06 12 0.13 -3.38
Net Nonoperating Obligations (NNO)		 155 161 164 154 151 146 135 120 112 77 64
Total Depreciation and Amortization (D&A)		 2.89 2.69 2.70 2.67 2.58 2.45 3.35 2.72 2.04 2.18 2.79
Debt-free, Cash-free Net Working Capital to Revenue		 -11.12% -0.04% 5.04% 6.24% 2.66% 0.02% 4.54% 1.39% 0.84% -2.46% -3.73%
Debt-free Net Working Capital to Revenue		 26.36% 31.04% 36.17% 40.08% 40.96% 44.27% 52.83% 33.56% 35.57% 27.50% 32.10%
Net Working Capital to Revenue		 26.36% 31.04% 36.17% 15.75% 14.69% 19.70% 29.21% 33.56% 35.57% 27.50% 32.10%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.29) $0.58 ($6.66) ($7.50) ($0.54) ($0.57) $0.50 ($0.06) ($0.30) ($0.12) $0.04
Adjusted Weighted Average Basic Shares Outstanding		 40.22M 41.19M 41.72M 41.80M 41.64M 42.90M 43.22M 43.26M 43.18M 44.95M 45.10M
Adjusted Diluted Earnings per Share		 ($0.29) $0.53 ($6.66) ($7.50) ($0.49) ($0.57) $0.46 ($0.06) ($0.26) ($0.12) $0.04
Adjusted Weighted Average Diluted Shares Outstanding		 40.22M 49.26M 41.72M 41.80M 41.64M 42.90M 51.53M 43.26M 43.18M 44.95M 46.90M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 41.14M 41.67M 41.78M 41.80M 42.83M 43.20M 43.26M 43.32M 44.94M 45.02M 45.19M
Normalized Net Operating Profit after Tax (NOPAT)		 3.32 41 -5.42 2.56 -6.23 -4.11 14 -0.07 -0.76 26 -1.62
Normalized NOPAT Margin		 4.11% 30.00% -7.98% 3.63% -11.36% -8.07% 18.11% -0.11% -1.26% 22.57% -2.53%
Pre Tax Income Margin		 0.43% 42.07% -392.67% -504.82% -37.19% -36.58% 20.58% -1.27% -9.02% 26.12% -4.64%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.72 18.54 -84.99 -114.14 -6.04 -4.91 6.57 0.30 -2.56 18.54 -1.46
NOPAT to Interest Expense		 -41.53 7.42 -59.49 -80.04 -4.34 -3.49 8.62 -0.28 -0.72 -3.07 -1.16
EBIT Less CapEx to Interest Expense		 0.23 18.25 -85.58 -114.39 -6.50 -5.31 5.71 -2.87 -4.32 17.18 -1.79
NOPAT Less CapEx to Interest Expense		 -42.02 7.13 -60.08 -80.29 -4.81 -3.89 7.76 -3.45 -2.48 -4.42 -1.48
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -8.70% -27.98% -3.62% -1.71% -1.68% -0.79% -0.68% -8.57% -12.72% 2,552.84% -39.51%

Financials Breakdown Chart

Key Financial Trends

Cerence (NASDAQ: CRNC) showed a meaningful operational improvement in Q2 2026, but the broader multi-year picture still shows a highly volatile, highly leveraged business with inconsistent profitability.

For the quarter ended March 31, 2026, Cerence generated $64.2 million in revenue and $1.7 million in net income, compared with a $5.2 million loss in Q1 2026. Operating income also improved sharply to a $2.4 million operating loss from a $29.3 million operating profit in the prior quarter, but Q2 still marked a return to modest profitability after several uneven periods.

Cash generation was a bright spot. Cerence produced $14.1 million in operating cash flow in Q2 2026 and ended the quarter with $108.3 million in cash and equivalents. That said, the balance sheet still carries $172.7 million in long-term debt, and total liabilities of $458.4 million remain high relative to equity of $158.5 million.

Looking at the last several years, Cerence has swung between profitable and deeply loss-making quarters. Revenue has generally been in the $50 million to $80 million quarterly range recently, but profitability has been hurt by restructuring charges, interest expense, and in some earlier periods very large non-cash impairment charges. The company’s cost structure has improved versus the extreme losses seen in parts of 2024, but the business is not yet consistently stable.

  • Q2 2026 returned to profitability, with net income of $1.7 million versus a $5.2 million loss in Q1 2026.
  • Operating cash flow was solid at $14.1 million in Q2 2026, supporting liquidity.
  • Cash and equivalents increased to $108.3 million at March 31, 2026, up from $92.1 million in Q1 2026.
  • Revenue held at $64.2 million, showing the business still generates a meaningful recurring top line.
  • Operating expenses improved materially from Q1 2026, helping the company get back near breakeven.
  • Gross margin remains healthy relative to the cost of revenue, but operating leverage is still inconsistent.
  • Deferred revenue remains sizable, with current and noncurrent deferred revenue together above $198 million, which can support future revenue recognition.
  • Short-term debt was eliminated by Q2 2026, leaving only long-term debt on the balance sheet.
  • Long-term debt of $172.7 million still creates financial leverage and interest burden.
  • Equity is thin relative to liabilities, and retained earnings remain deeply negative, reflecting years of accumulated losses.

Bottom line: Cerence is showing signs of stabilization in 2026, especially in cash flow and quarterly earnings, but investors should still view the stock as a turnaround story. The latest quarter was encouraging, yet the company needs several more periods of consistent revenue and profitability to reduce balance-sheet and execution risk.

07/14/26 08:55 AM ETAI Generated. May Contain Errors.

Cerence Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cerence's financial year ends in September. Their financial year 2025 ended on September 30, 2025.

Cerence's net income appears to be on an upward trend, with a most recent value of -$18.71 million in 2025, falling from $5.88 million in 2018. The previous period was -$588.08 million in 2024. View Cerence's forecast to see where analysts expect Cerence to go next.

Cerence's total operating income in 2025 was -$2.29 million, based on the following breakdown:
  • Total Gross Profit: $183.14 million
  • Total Operating Expenses: $185.43 million

Over the last 7 years, Cerence's total revenue changed from $276.98 million in 2018 to $251.78 million in 2025, a change of -9.1%.

Cerence's total liabilities were at $479.92 million at the end of 2025, a 14.5% decrease from 2024, and a 15.4% increase since 2019.

In the past 6 years, Cerence's cash and equivalents has ranged from $0.00 in 2019 to $136.07 million in 2020, and is currently $84.02 million as of their latest financial filing in 2025.

Over the last 7 years, Cerence's book value per share changed from 0.00 in 2018 to 3.48 in 2025, a change of 347.8%.


Related Companies

Financial statements for NASDAQ:CRNC last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Under $1 while the market panics
The new deadline for crypto’s best bill, the Clarity Act, is August 7th. That's the Senate's final session day...
Crypto 101 Media | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
BSEM Announces Major Corporate Milestone
BioStem Technologies (OTC: BSEM) has publicly filed a Form 10 registration statement with the SEC, advancing i...
Huge Alerts | Sponsoredtc pixel
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
American’s Biggest Threat Is Here
This feels like one of those ''where were you when Kennedy was shot'' moments. It felt like a moment in time, ...
Goldco Direct, LLC | Sponsoredtc pixel
They proved it worked in '76. Then buried it.
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel